All Stories

  1. Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus
  2. Inhibition of adipocyte-derived fatty-acid-binding protein 4 reduces adipocyte inflammation, improves angiogenesis, and facilitates wound healing in metabolic dysfunctions
  3. High-density lipoprotein protects vascular endothelial cells from indoxyl sulfate insults through its antioxidant ability
  4. Abstract 11795: CXCL5 Inhibition Recovers Neovascularization in Diabetes Mellitus
  5. Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease
  6. Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
  7. CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
  8. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease
  9. Tributyrin Intake Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm in LDLR-/- Mice
  10. Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan
  11. Abstract 9464: Adipocyte-Derived Fatty-Acid-Binding Protein 4 Impairs Human Dermal Microvascular Endothelial Cells Under Hypoxia Insults - A Mechanistic Clue to Impaired Wound Healing in Obesity
  12. CCL4 Deletion Accelerates Wound Healing by Improving Endothelial Cell Functions in Diabetes Mellitus
  13. Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy
  14. Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection
  15. Abstract 8907: Fatty-Acid-Binding Protein 3 as a Novel Inducer of Adhesion Molecules in Atherosclerosis
  16. Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus
  17. Significance of serum FGF-23 for risk assessment of contrast-associated acute kidney injury and clinical outcomes in patients undergoing coronary angiography
  18. Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy
  19. Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway
  20. Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis
  21. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation
  22. Association between Preoperative Nutritional Status and Clinical Outcomes of Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
  23. The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy
  24. Pulmonary hemodynamics and wave reflections in adults with atrial septal defects
  25. A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
  26. Inhibition of Serine Protease Activity Protects Against High Fat Diet-Induced Inflammation and Insulin Resistance
  27. Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency
  28. The Mediterranean diet reduces the genetic risk of chromosome 9p21 for myocardial infarction in an Asian population community cohort
  29. Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair
  30. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure
  31. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
  32. Inhibition of macrophage inflammatory protein-1β improves endothelial progenitor cell function and ischemia-induced angiogenesis in diabetes
  33. Increased activin A levels in prediabetes and association with carotid intima-media thickness: a cross-sectional analysis from I-Lan Longitudinal Aging Study
  34. MP482IVABRADINE IN ANGIOGENESS OF DIABETIC MICE
  35. Risk of Febuxostat-Associated Myopathy in Patients with CKD
  36. Usefulness of the CHADS2 Score for Prognostic Stratification in Patients With Coronary Artery Disease Having Coronary Artery Bypass Grafting
  37. Effect of dyad training on medical students’ cardiopulmonary resuscitation performance
  38. Direct Renin Inhibition with Aliskiren Improves Ischemia-Induced Neovasculogenesis in Diabetic Animals via the SDF-1 Related Mechanism
  39. Clinical and Genetic Factors for Thiazide-Induced Hyponatremia
  40. Indicators associated with coronary atherosclerosis in metabolic syndrome
  41. Prognostic Value of Circulating Adipokine Levels and Expressions of Adipokines in the Myocardium of Patients With Chronic Heart Failure
  42. L-006 GENOME-WIDE SCAN FOR YOUNG-ONSET HYPERTENSION IN HAN CHINESE IN TAIWAN
  43. Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension
  44. EFFECT OF ANNUAL INFLUENZA VACCINATION ON MORTALITY AND HOSPITALIZATION IN PATIENTS WITH CHRONIC HEART DISEASE
  45. Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke
  46. Estimation of central systolic blood pressure using an oscillometric blood pressure monitor
  47. S22-3 Biomarkers for Advanced Risk Stratification
  48. Predictors of inexplicable coronary artery spasm during coronary angiography in patients with stable angina — The role of intravascular oxidative stress
  49. S4-1 MEDICAL THERAPY FOR ACUTE MYOCARDIAL INFARCTION
  50. S37-4 ADHESION MOLECULES IN CONGESTIVE HEART FAILURE
  51. Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure
  52. Multimarker Approach to Risk Stratification Among Patients with Advanced Chronic Heart Failure
  53. Antiphospholipid Syndrome Presenting as Intracardiac Thrombus With Pulmonary Embolism
  54. Insulin Deficiency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium
  55. The “ribbon sign” of aortic coarctation
  56. Clinical characteristics of young-onset hypertension—implications for different genders
  57. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure
  58. Atherosclerotic Left Main Coronary Artery Aneurysm?Case Reports
  59. P4-03 Modulation of the gene expression profile by Ginkgo Biloba in TNF-α-treated human aortic endothelial cells
  60. Differentiating Syndrome X from Coronary Artery Disease by Treadmill Exercise Test in Patients with Chest Pain and Exercise-Induced Myocardial Ischemia